Michael Plank

Head of R&D

Medea Biopharma GmbH

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Michael Plank is the Head of R&D at Medea Biopharma GmbH in Germany. His research focuses on proteomics, signaling pathways in yeast, and the development of novel inhibitors and chemical genetics. Recent articles authored by Dr. Plank explore dynamic data acquisition in proteomics, TOR and PKA signaling interactions, and the role of AGC-kinases in cellular processes.

Articles (7)

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Robbie Loewith

Full Professor

University of Geneva

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Michael Plank

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Modern Data Acquisition Approaches in Proteomics Based on Dynamic Instrument Control

Interaction of TOR and PKA Signaling in S. cerevisiae

Identification of a Covalent Importin-5 Inhibitor, Goyazensolide, from a Collective Synthesis of Furanoheliangolides

Phosphoproteomic Effects of Acute Depletion of PP2A Regulatory Subunit Cdc55

Chemical Genetics of AGC-kinases Reveals Shared Targets of Ypk1, Protein Kinase A and Sch9.

Chemical Genetics of AGC-kinases Reveals Shared Targets of Ypk1, Protein Kinase A and Sch9

The Aspartic Protease Ddi1 Contributes to DNA-Protein Crosslink Repair in Yeast.

Collaborators (1)

Robbie Loewith

Make your next move.